A Phase III Randomized, Double-Blind, Placebo-controlled Trial of pembrolizumab (MK-3475/SCH900475) in Combination with Etoposide/Platinum (Cisplatin or Carboplatin) for the First-line Treatment of Subjects with Extensive Stage Small Cell Lung Cancer (KEYNOTE-604)
Supported projects > Other Supported Projects · 2017
Authors: Tuncay GÖKSEL
2017-2021, Other Supported Projects, R & D Project, Continues